Maribao, Arries Skyler Y.
HRN: 22-75-00 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/30/2025
10/09/2025
PO
300 Mg / 12 Ml
Q 8 Hours
Intestinal Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes